Wave Life Sciences Studies Fourth Quarter and Full Yr 2021 Monetary Outcomes and Supplies Enterprise Replace

Wave Life Sciences USA, Inc.

Medical information from a number of novel, PN-modified stereopure oligonucleotides for ALS/FTD, DMD, and HD anticipated in 2022

GalNAc-AIMers restore therapeutically related ranges of AAT for lung safety and scale back liver-damaging aggregates in preclinical examine; IND enabling toxicology research anticipated to provoke in 3Q 2022

FY2021 year-end money whole of $150.6 million offering runway into 2Q 2023

Wave to host investor convention name and webcast at 8:30 a.m. ET at present

CAMBRIDGE, Mass., March 03, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines firm dedicated to delivering life-changing

Read More Read More

Guardion Well being Sciences to Wind Down VectorVision Enterprise Operations and Deal with Exploiting VectorVision Mental Property

Administration Anticipates $300,000+ Discount in Annual Working Prices

HOUSTON, Dec. 23, 2021 (GLOBE NEWSWIRE) — Guardion Well being Sciences, Inc. (“Guardion” or the “Firm”) (Nasdaq: GHSI), a medical diet firm that develops clinically supported diet, medical meals, and dietary supplements, introduced that, as a part of its ongoing complete analysis of its enterprise, it’s going to wind down the enterprise operations of its VectorVision enterprise and, as an alternative, give attention to exploiting its invaluable mental property and expertise utilizing a restructured and extra cost-efficient strategy.

The Firm is exploring each home and worldwide enterprise alternatives, resembling licensing and distribution

Read More Read More